World's Best Scientists 2026 revealed!
Current Neuropharmacology
H-index 26

Current Neuropharmacology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Neuroscience 173 99 106 17
Medicine 1286 69 77 19

Additional Metrics

Number of Best Scientists*: 267
Documents by Best Scientists*: 265
Top 100 Ranked Scientists*: 1
SCIMAGO H-index: 112
SCIMAGO SJR: 1.555
Impact Factor: 5.3

Overview

Top Research Topics at Current Neuropharmacology?

Current Neuropharmacology facilitates discussions on Neuroscience, Pharmacology, Bioinformatics, Disease and Neuroprotection. Central nervous system is a primary topic of Neuroscience research in the journal. Studies on Pharmacology discussed in the journal link to the field of Dopamine.

The Dopamine research dealing mostly with Dopaminergic is the focus of the journal. Specifically, studies on Clinical trial are prevalent in the Bioinformatics works discussed. It concentrated on Disease research, specifically Dementia and Parkinson's disease.

The journal dives deep in exploring the relationship between the study of Neuroprotection and Oxidative stress.

  • Neuroscience (40.83%)
  • Pharmacology (19.54%)
  • Bioinformatics (14.57%)

What are the most cited papers published in the journal?

  • Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. (2182 citations)
  • Acetylcholinesterase Inhibitors: Pharmacology and Toxicology (1064 citations)
  • Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation. (459 citations)

Research areas of the most cited articles at Current Neuropharmacology:

The journal publications primarily tackle Neuroscience, Pharmacology, Disease, Neurodegeneration and Neuroprotection. The most cited publications address concerns in the field of Neuroscience by exploring it in line with topics in Synaptic plasticity which intersect with Neurotransmission subjects. The published papers focus on Pharmacology but sometimes tackle the closely related topic of NMDA receptor which is concerned with Ketamine.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Gene
  • Disease

The previous edition focused in particular on these issues:

The journal is organized to address concerns in the fields of Neuroscience, Disease, Bioinformatics, Neuroprotection and Oxidative stress. It explores Neuroscience concepts, specifically Central nervous system but expands to research in Mechanism (biology). The featured works in Amyotrophic lateral sclerosis and Tau protein, which all belong in the domain if Disease, also overlaps with concepts under Context (language use).

The journal focuses on Bioinformatics but the discussions also offer insight into other areas such as Dementia, Pathogenesis and Anxiety. The journal is concerned with the study of Neuroprotection and Pharmacology in general. The Neuroinflammation study which was featured in it aims to expound on the research in Inflammation.

The most cited articles from the last journal are:

  • Alzheimer's Disease: New Concepts on the Role of Autoimmunity and NLRP3 Inflammasome in the Pathogenesis of the Disease. (6 citations)
  • Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis. (5 citations)
  • Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations. (5 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Current Neuropharmacology (based on the number of publications) are:

  • Ichiro Sora (15 papers) absent at the last edition,
  • Gabriele Sani (13 papers) absent at the last edition,
  • Paolo Girardi (12 papers) published 1 paper at the last edition,
  • Masaomi Iyo (12 papers) published 1 paper at the last edition,
  • Georgios D. Kotzalidis (12 papers) published 1 paper at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Current Neuropharmacology (based on the number of publications) are:

  • Sapienza University of Rome (57 papers) published 11 papers at the last edition, 7 more than at the previous edition,
  • Jilin University (17 papers) published 4 papers at the last edition,
  • Tohoku University (16 papers) published 1 paper at the last edition,
  • Shanghai Jiao Tong University (15 papers) published 4 papers at the last edition, 2 more than at the previous edition,
  • University of Catania (14 papers) published 1 paper at the last edition, 3 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 8.12% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 14.92% were posted by at least one author from the top 10 institutions publishing in the journal. Another 5.52% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 20.99% of all publications and 58.56% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Development in Neuropharmacology

A career in neuropharmacology presents countless opportunities to expand the scientific landscape, enhance patient care, and contribute to global health advancements. The nature of the field is undeniably complex, requiring years of formal education and extensive training. An aspirant must consider that education and training commitments significantly vary; depending on the area of specialization, acquiring clinical or research expertise typically requires considerable time and effort. A career in speech-language pathology, for instance, is one way practitioners can combine their interests in language and neurological development. This role envisions diagnosing, treating, and researching communication and swallowing disorders developed from a variety of causes, including stroke, brain injury, developmental delay, Parkinson’s disease, and more. However, the avenue to becoming a competent professional in the field doesn't end upon obtaining the necessary credentials but is built with ongoing learning and staying abreast with the latest research and advancements such as the studies published in well-respected journals including Current Neuropharmacology. For those specifically interested in speech-language pathology within neuropharmacology, you might want to learn how to become a speech therapist in Colorado. This will equip you with an understanding of the academic path, necessary exams, potential financial investment, job outlook, and professional requirements in the field. Embarking on a career in neuropharmacology is an exciting and rewarding journey that opens doors for various professional opportunities and growth. It offers you a chance to contribute significantly to scientific development while improving the quality of life for patients worldwide.

Top Publications

  • The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress.

    Ganesh Raghu;Michael Berk;Peter A Campochiaro;Hartmut Jaeschke

    (2021)
    154 Citations
  • Role of Nitric Oxide in Neurodegeneration: Function, Regulation, and Inhibition.

    Devesh Tewari;Archana N. Sah;Sweta Bawari;Seyed F. Nabavi

    (2020)
    97 Citations
  • Treatment of Posttraumatic Stress Disorder: a State-of-the-art Review.

    (2023)
    90 Citations
  • Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry

    H Fanet;L Capuron;N Castanon;F Calon

    (2021)
    77 Citations
  • Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry

    (2020)
    75 Citations
  • The Dual Role of Microglia in Blood-Brain Barrier Dysfunction after Stroke.

    Ruiqing Kang;Marcin Gamdzyk;Cameron Lenahan;Jiping Tang

    (2020)
    70 Citations
  • Inhibition of Caspase 3 and Caspase 9 Mediated Apoptosis: A Multimodal Therapeutic Target in Traumatic Brain Injury

    (2022)
    70 Citations
  • The Stroke-Induced Blood-Brain Barrier Disruption: Current Progress of Inspection Technique, Mechanism, and Therapeutic Target

    Takeshi Okada;Hidenori Suzuki;Zachary D. Travis;John H. Zhang

    (2020)
    64 Citations
  • Drug Choices and Advancements for Managing Depression in Parkinson's Disease.

    Francesca Assogna;Clelia Pellicano;Cinzia Savini;Lucia Macchiusi

    (2020)
    52 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their medical career options, pursuing related online degrees can provide valuable skills and credentials. For example, an mba healthcare management online program offers healthcare professionals the leadership and business expertise to advance into administrative and executive roles.

Nurses looking to advance their clinical knowledge without prior nursing experience can explore programs designed to transition from a non nursing degree to bsn online. These accelerated options help streamline entry into nursing careers while balancing work and study.

For those aiming to become advanced practice registered nurses, understanding compensation trends is essential. The psych np salary varies by location but generally reflects the growing need for mental health specialists in diverse settings.

If you’re exploring how to expedite your path in nursing, knowing how to become nurse practitioner in the shortest time can help you plan effectively and reduce time spent on education without sacrificing quality.

Best Scientists Contributing to This Journal

Recently Published Articles